Cellectis said on Monday that AstraZeneca had finalized its additional $140 million investment in the company, in line with the deal announced last November.The biotech company, which specializes in.
• Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting • Execution of strategic.
Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.